Adirondack Trust Company’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47
| Closed | -$3.04K | – | 502 |
|
|
2024
Q1 | $3.04K | Hold |
47
| – | – | ﹤0.01% | 446 |
|
|
2023
Q4 | $3.08K | Sell |
47
-602
| -93% | -$39.5K | ﹤0.01% | 441 |
|
|
2023
Q3 | $37K | Hold |
649
| – | – | 0.02% | 246 |
|
|
2023
Q2 | $41.2K | Sell |
649
-51
| -7% | -$3.24K | 0.02% | 222 |
|
|
2023
Q1 | $43.9K | Hold |
700
| – | – | 0.02% | 212 |
|
|
2022
Q4 | $44.4K | Hold |
700
| – | – | 0.02% | 211 |
|
|
2022
Q3 | $41K | Buy |
+700
| New | +$41K | 0.02% | 209 |
|